Keeley-Teton Advisors’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$4.44M Sell
7,211
-20
-0.3% -$11.4K 0.54% 46
2024
Q4
$3.83M Buy
7,231
+611
+9% +$344K 0.44% 68
2024
Q3
$3.98M Buy
6,620
+589
+10% +$334K 0.44% 69
2024
Q2
$3.27M Buy
6,031
+842
+16% +$482K 0.42% 80
2024
Q1
$3.33M Sell
5,189
-4,899
-49% -$2.98M 0.41% 83
2023
Q4
$5.9M Sell
10,088
-629
-6% -$352K 0.76% 26
2023
Q3
$5.57M Sell
10,717
-193
-2% -$100K 0.78% 23
2023
Q2
$5.91M Sell
10,910
-2,687
-20% -$1.47M 0.76% 23
2023
Q1
$7.31M Sell
13,597
-378
-3% -$193K 0.9% 19
2022
Q4
$7.13M Sell
13,975
-944
-6% -$460K 0.89% 18
2022
Q3
$6.51M Sell
14,919
-346
-2% -$166K 0.89% 18
2022
Q2
$7.17M Sell
15,265
-249
-2% -$121K 0.9% 17
2022
Q1
$7.86M Sell
15,514
-515
-3% -$247K 0.82% 21
2021
Q4
$8.48M Sell
16,029
-728
-4% -$350K 0.9% 20
2021
Q3
$7.79M Sell
16,757
-168
-1% -$79.2K 0.85% 25
2021
Q2
$8.03M Buy
16,925
+3,930
+30% +$1.89M 0.85% 30
2021
Q1
$5.97M Buy
12,995
+1,391
+12% +$682K 0.63% 55
2020
Q4
$6.18M Sell
11,604
-5,483
-32% -$2.69M 0.83% 31
2020
Q3
$8.21M Sell
17,087
-996
-6% -$489K 1.34% 10
2020
Q2
$8.16M Sell
18,083
-6,617
-27% -$2.95M 1.28% 9
2020
Q1
$10.7M Buy
24,700
+2,003
+9% +$894K 1.9% 3
2019
Q4
$9.97M Sell
22,697
-1,572
-6% -$661K 1.05% 15
2019
Q3
$10.1M Sell
24,269
-4,451
-15% -$1.82M 1.07% 15
2019
Q2
$10.4M Buy
28,720
+20,215
+238% +$6.76M 1.01% 22
2019
Q1
$2.72M Sell
8,505
-98
-1% -$30.1K 0.24% 111
2018
Q4
$2.44M Sell
8,603
-650
-7% -$196K 0.24% 102
2018
Q3
$2.96M Sell
9,253
-30
-0.3% -$9.56K 0.21% 103
2018
Q2
$2.99M Sell
9,283
-2,462
-21% -$770K 0.21% 110
2018
Q1
$3.21M Sell
11,745
-200
-2% -$53K 0.21% 97
2017
Q4
$2.9M Sell
11,945
-1,100
-8% -$250K 0.18% 116
2017
Q3
$2.64M Sell
13,045
-200
-2% -$39.3K 0.14% 125
2017
Q2
$2.71M Sell
13,245
-500
-4% -$99.6K 0.13% 117
2017
Q1
$2.51M Buy
+13,745
New +$2.4M 0.11% 122

Other funds holding CHE

Keeley-Teton Advisors's CHE Position: Q1 2025 in Review

Keeley-Teton Advisors reduced its Chemed (CHE) stake by 0.28% in Q1 2025, selling an estimated $11.4K and leaving 7,211 shares worth $4.44M. The position accounts for 0.54% of the portfolio, ranked #46.

Keeley-Teton Advisors first reported a position in CHE in Q1 2017 and has held it in 33 quarters since. The position peaked at $10.7M in Q1 2020. 553 funds tracked by Wall St. Rank hold CHE as of Q1 2025.

  • Keeley-Teton Advisors held 7,211 shares of Chemed worth $4.44M as of Q1 2025.
  • Keeley-Teton Advisors sold 20 Chemed shares in Q1 2025, an estimated $11.4K.
  • Chemed made up 0.54% of Keeley-Teton Advisors's portfolio in Q1 2025, its #46 holding.
  • Keeley-Teton Advisors first reported a position in Chemed in Q1 2017 and has held it in 33 quarters since.
  • Keeley-Teton Advisors's Chemed position peaked at $10.7M in Q1 2020.
  • 553 funds tracked by Wall St. Rank held Chemed as of Q1 2025.

Based on Keeley-Teton Advisors's 13F filing for Q1 2025, filed 14 May 2025.